With the increasing number of reports documenting a prevalence of ALT in some pediatric cancers (Heaphy et al., 2011; Dorris et al., 2014; Deeg et al., 2017) the role of the embryonic origin of these tumors in the ability to activate telomerase or ALT during cancer progression is becoming evident. The gene discussed is GPT; the disease is cancer.